Manhasset, NY – Feinstein Institute Investigator Bruce T. Volpe, MD and colleagues from Massachusetts Institute of Technology (MIT) have been studying the use of robots in stroke recovery. Now they have shown that robots can cut cost and time of Phase III stroke drug trials by 70 percent. In addition to executing interactive motor training, the robots routinely record crucial aspects of all movements enabling a more sensitive measure of performance and the decreased variance leads to improved outcome measures. Dr. Volpe and his colleagues have published these results in the journal Stroke.
Click here to view an article about the paper and collaboration with MIT.
About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson’s disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit FeinsteinInstitute.org.